Simultaneous measurement of atrial and ventricular pacemaker activity

Area of Science:

• Pharmacology and Cardiovascular Physiology
• Cardiac Electrophysiology Research

Background:

• Understanding drug effects on cardiac pacemakers is crucial for treating arrhythmias.
• Simultaneous assessment of atrial and ventricular pacemaker activity provides comprehensive insights.

Purpose of the Study:

• To evaluate the impact of quinidine on atrial and ventricular pacemaker activity.
• To compare the sensitivity of atrial versus ventricular pacemakers to quinidine.

Main Methods:

• Utilized an isolated perfused rat heart model.
• Induced complete atrio-ventricular dissociation by ligating the Bundle of His.
• Monitored pacemaker rates following perfusion with quinidine.

Main Results:

• Quinidine decreased the rate of both atrial and ventricular pacemakers.
• The ventricular pacemaker exhibited greater susceptibility to quinidine's depressant effects.
• Pacemaker rates remained stable for up to 2 hours in the experimental setup.

Conclusions:

• Quinidine exerts a dose-dependent depressant effect on both atrial and ventricular pacemakers.
• Ventricular pacemakers are more vulnerable to quinidine than atrial pacemakers, highlighting differential electrophysiological responses.